Compare MAIA & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAIA | AMPG |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 82.0M |
| IPO Year | 2022 | 2012 |
| Metric | MAIA | AMPG |
|---|---|---|
| Price | $1.01 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 246.6K | ★ 676.3K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 69.44 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $25,195,930.00 |
| Revenue This Year | N/A | $44.47 |
| Revenue Next Year | N/A | $64.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 164.99 |
| 52 Week Low | $0.87 | $1.64 |
| 52 Week High | $3.19 | $10.11 |
| Indicator | MAIA | AMPG |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 30.80 |
| Support Level | N/A | $1.75 |
| Resistance Level | $1.48 | $2.18 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 23.11 | 5.18 |
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.